Pages
-
-
Apolipoprotein-CIII O-glycosylation, a link between GALNT2 and plasma lipids
-
-
Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits
-
-
Potential value of identifying type 2 diabetes subgroups for guiding intensive treatment
-
-
Identification of biomarkers for glycaemic deterioration in type 2 diabetes
-
-
Altered blood gene expression in the obesity-related type 2 diabetes cluster may be causally involved in lipid metabolism
-
-
Serum Magnesium Is Inversely Associated With Heart Failure, Atrial Fibrillation, and Microvascular Complications in Type 2 Diabetes
-
-
Prognostic models for predicting the risk of foot ulcer or amputation in people with type 2 diabetes
-
-
Predicting negative health outcomes in older general practice patients with chronic illness
-
-
A prognostic model predicted deterioration in health-related quality of life in older patients with multimorbidity and polypharmacy
-
-
Are anticholinergic symptoms a risk factor for falls in older general practice patients with polypharmacy?
-
-
Sleep characteristics across the lifespan in 1.1 million people from the Netherlands, United Kingdom and United States
-
-
Sleep characteristics across the lifespan in 1.1 million people from the Netherlands, United Kingdom and United States
-
-
Serum matrix metalloproteinases and left atrial remodeling-the Hoorn study
-
-
Predicting and elucidating the etiology of fatty liver disease
-
-
Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting
-
-
Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes
-
-
Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug-metabolite atlas
-
-
Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug-metabolite atlas
-
-
Metformin and statin use associate with plasma proteinN-glycosylation in people with type 2 diabetes
-
-
Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes
-
-
Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort
-
-
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
-
-
Variation in the plasma membrane monoamine transporter (PMAT) (encoded by SLC29A4) and organic cation transporter 1 (OCT1) (encoded by SLC22A1) and gastrointestinal intolerance to metformin in type 2 diabetes
-
-
A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy
Pages